Filter events


  • Viral particles on the cell surface of Chikungunya virus-infected fibroblasts

    Press release | 02.03.2015

    Themis Bioscience’s Chikungunya Vaccine Study Results Published

    Phase 1 trial of the vaccine candidate which was developed under an R&D collaboration between Themis Bioscience GmbH and the Institut Pasteur (Paris) shows good immunogenicity, safety and tolerability.

  • Press release | 03.02.2015

    Moderna and Institut Pasteur Sign Strategic Research Collaboration

    Moderna Therapeutics, a pioneer in the development of messenger RNA (mRNA) Therapeutics™ and the Institut Pasteur, today announced a long-term strategic research collaboration for the discovery and development of drugs and vaccines using Moderna’s mRNA Therapeutics™ platform. Valera, a Moderna venture company, will manage the research collaboration for Moderna.

  • Patronage: the Institut Pasteur and the Total Foundation renew their common commitment against infectious diseases © Institut Pasteur

    Press release | 27.01.2015

    Patronage: the Institut Pasteur and the Total Foundation renew their common commitment against infectious diseases

    For 10 years, Total and its corporate foundation working alongside the Institut Pasteur and its International Network in the fight against infectious diseases. A new sponsorship agreement, of EUR 6 million for three years, was signed on 26 January 2015. It will provide funding, for public health and research projects in resource limited countries in order to better understand the therapeutic and vaccine responses in children.

  • Transmission tree of Ebola virus. Ebola: Study of the chains of transmission in Conakry © Institut Pasteur

    Press release | 23.01.2015

    Ebola: Study of the chains of transmission in Conakry

    Researchers at the Institut Pasteur of Dakar and the Institut Pasteur in Paris have reconstructed chains of transmission of Ebola virus in the capital city of Guinea, from February to August 2014. The data show the positive impact of control measures on the evolution of the epidemic but highlight the challenges of Ebola control in large urban centres.

  • Laboratoire d'Excellence, project Milieu Intérieur © Institut Pasteur

    Press release | 16.01.2015

    The biological basis of good health

    In a biological sense, what does it mean to be “in good health”? This far-reaching question is the focus of the “Laboratoire d'Excellence” project Milieu Intérieur (“Environment Within”). The Milieu Intérieur cohort is the first French cohort of its kind, comprised of a thousand healthy donors. Studying this cohort will help define the parameters of a healthy immune system. The recent analysis of the initial results generated from the cohort represents an important milestone for the scientists in this consortium.

  • 3D structure of the antibody complexes for all four serotypes bound to the dengue virus envelope protein. © Institut Pasteur

    Press release | 14.01.2015

    Identification of an Achilles heel in the dengue virus gives new hope for vaccine development

    Scientists have identified a vulnerable site on the surface of the dengue virus which is targeted by the only broadly neutralizing antibodies identified to date. This discovery offers a new target for the development of a vaccine to combat all four types of dengue virus currently in circulation.

  • Press release | 12.12.2014

    Malaria: formal identification of the artemisinin resistance gene

    Together with teams from Columbia University (USA), CNRS in Toulouse and NIH/NIAID (USA), Institut Pasteur scientists based in Paris and Cambodia have recently provided the key demonstration that K13 is indeed the main determinant of artemisinin resistance in Plasmodium falciparum parasites. This work is a landmark for the scientific community, as it provides a validated molecular marker for artemisinin resistance, which currently poses a major public health problem. This work is published in the journal Science.

  • © Institut Pasteur

    Press release | 04.12.2014

    Institut Pasteur Graduation Ceremony 2014

    The Institut Pasteur will host on the 12th of December 2014  the 2nd ceremony in honor of its graduating PhD class, with the  Doctors having defended in 2013-2014. This ceremony will be chaired by Pr Christian Bréchot, President of the Institut Pasteur. It will be held in presence of Jean-Philippe Pierre, deputy mayor of the 15th arrondissement of Paris.

  • Press release | 27.11.2014

    Ebola: a new Institut Pasteur is soon to be created in Guinea

    Pr Christian Bréchot, President of the Institut Pasteur, will be in Guinea Friday 28th November 2014, alongside François Hollande, President of the French Republic. Two agreements will be signed, one with the government of Guinea and the other one with the French Agency for Development (AFD), allowing for the creation of a new Pasteur Institute in Conakry in late 2016. On Saturday 29th, Pr. Bréchot will visit the Macenta treatment Center where the Institut Pasteur is setting-up a diagnostic laboratory.

  • Chikungunya virus particles on the surface of an infected cell  © Institut Pasteur/Thérèse Couderc

    Press release | 20.11.2014

    Chikungunya fever: Themis Bioscience’s vaccine candidate successful in phase 1

    The induction of neutralizing antibodies by a prophylactic Chikungunya vaccine candidate has now been confirmed by the final results of a phase 1 clinical trial, as well as its tolerability and safety. Detailed information of the trial has been presented at two international conferences. The vaccine candidate was developed under a R&D collaboration between Themis Bioscience GmbH and the Institut Pasteur (Paris) based upon a measles vaccine vector technology.



Zoom in on...

Pasteur museum

Welcome to Pasteur Museum


The Pasteur Museum is located at the Institut Pasteur, situated at: 25 rue du Docteur Roux 75015 Paris, France

Pasteur Museum